Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

Cigarette smoke disrupts monolayer integrity by altering epithelial cell-cell adhesion and cortical tension.

Nishida K, Brune KA, Putcha N, Mandke P, O'Neal WK, Shade D, Srivastava V, Wang M, Lam H, An SS, Drummond MB, Hansel NN, Robinson DN, Sidhaye VK.

Am J Physiol Lung Cell Mol Physiol. 2017 Sep 1;313(3):L581-L591. doi: 10.1152/ajplung.00074.2017. Epub 2017 Jun 22.

2.

HIV Impairs Lung Epithelial Integrity and Enters the Epithelium to Promote Chronic Lung Inflammation.

Brune KA, Ferreira F, Mandke P, Chau E, Aggarwal NR, D'Alessio FR, Lambert AA, Kirk G, Blankson J, Drummond MB, Tsibris AM, Sidhaye VK.

PLoS One. 2016 Mar 1;11(3):e0149679. doi: 10.1371/journal.pone.0149679. eCollection 2016.

3.

Characteristic Changes in Cell Surface Glycosylation Accompany Intestinal Epithelial Cell (IEC) Differentiation: High Mannose Structures Dominate the Cell Surface Glycome of Undifferentiated Enterocytes.

Park D, Brune KA, Mitra A, Marusina AI, Maverakis E, Lebrilla CB.

Mol Cell Proteomics. 2015 Nov;14(11):2910-21. doi: 10.1074/mcp.M115.053983. Epub 2015 Sep 9.

4.

Importance of age of onset in pancreatic cancer kindreds.

Brune KA, Lau B, Palmisano E, Canto M, Goggins MG, Hruban RH, Klein AP.

J Natl Cancer Inst. 2010 Jan 20;102(2):119-26. doi: 10.1093/jnci/djp466. Epub 2010 Jan 12.

5.

Elevated cancer mortality in the relatives of patients with pancreatic cancer.

Wang L, Brune KA, Visvanathan K, Laheru D, Herman J, Wolfgang C, Schulick R, Cameron JL, Goggins M, Hruban RH, Klein AP.

Cancer Epidemiol Biomarkers Prev. 2009 Nov;18(11):2829-34. doi: 10.1158/1055-9965.EPI-09-0557. Epub 2009 Oct 20.

6.

Absence of germline BRCA1 mutations in familial pancreatic cancer patients.

Axilbund JE, Argani P, Kamiyama M, Palmisano E, Raben M, Borges M, Brune KA, Goggins M, Hruban RH, Klein AP.

Cancer Biol Ther. 2009 Jan;8(2):131-5. Epub 2009 Feb 4.

7.

Longitudinal in vivo analysis of the region-specific efficacy of parathyroid hormone in a rat cortical defect model.

Komatsu DE, Brune KA, Liu H, Schmidt AL, Han B, Zeng QQ, Yang X, Nunes JS, Lu Y, Geiser AG, Ma YL, Wolos JA, Westmore MS, Sato M.

Endocrinology. 2009 Apr;150(4):1570-9. doi: 10.1210/en.2008-0814. Epub 2008 Nov 20.

PMID:
19022894
8.

PancPRO: risk assessment for individuals with a family history of pancreatic cancer.

Wang W, Chen S, Brune KA, Hruban RH, Parmigiani G, Klein AP.

J Clin Oncol. 2007 Apr 10;25(11):1417-22.

9.

Patient perspective on the value of genetic counselling for familial pancreas cancer.

Axilbund JE, Brune KA, Canto MI, Brehon BC, Wroblewski LD, Griffin CA.

Hered Cancer Clin Pract. 2005 Aug 15;3(3):115-22. doi: 10.1186/1897-4287-3-3-115.

10.

Prospective risk of pancreatic cancer in familial pancreatic cancer kindreds.

Klein AP, Brune KA, Petersen GM, Goggins M, Tersmette AC, Offerhaus GJ, Griffin C, Cameron JL, Yeo CJ, Kern S, Hruban RH.

Cancer Res. 2004 Apr 1;64(7):2634-8.

11.

Selective enhancement of multipotential hematopoietic progenitors in vitro and in vivo by IL-20.

Liu L, Ding C, Zeng W, Heuer JG, Tetreault JW, Noblitt TW, Hangoc G, Cooper S, Brune KA, Sharma G, Fox N, Rowlinson SW, Rogers DP, Witcher DR, Lambooy PK, Wroblewski VJ, Miller JR, Broxmeyer HE.

Blood. 2003 Nov 1;102(9):3206-9. Epub 2003 Jul 10.

12.
13.

Evidence for a major gene influencing risk of pancreatic cancer.

Klein AP, Beaty TH, Bailey-Wilson JE, Brune KA, Hruban RH, Petersen GM.

Genet Epidemiol. 2002 Aug;23(2):133-49.

PMID:
12214307
14.

Evaluation of candidate genes MAP2K4, MADH4, ACVR1B, and BRCA2 in familial pancreatic cancer: deleterious BRCA2 mutations in 17%.

Murphy KM, Brune KA, Griffin C, Sollenberger JE, Petersen GM, Bansal R, Hruban RH, Kern SE.

Cancer Res. 2002 Jul 1;62(13):3789-93.

15.

Familial pancreatic cancer.

Klein AP, Hruban RH, Brune KA, Petersen GM, Goggins M.

Cancer J. 2001 Jul-Aug;7(4):266-73. Review.

PMID:
11561603
16.

Increased risk of incident pancreatic cancer among first-degree relatives of patients with familial pancreatic cancer.

Tersmette AC, Petersen GM, Offerhaus GJ, Falatko FC, Brune KA, Goggins M, Rozenblum E, Wilentz RE, Yeo CJ, Cameron JL, Kern SE, Hruban RH.

Clin Cancer Res. 2001 Mar;7(3):738-44.

18.

Characterization of thromboxane A2/prostaglandin H2 binding sites in guinea pig cardiac membrane preparations.

Bowling N, Dubé GP, Kurtz WL, Brune KA, Saussy DL Jr, Dorn GW 2nd, Mais DE.

J Mol Cell Cardiol. 1994 Jul;26(7):915-23.

PMID:
7966360
19.

Dipyridamole directly inhibits vascular smooth muscle cell proliferation in vitro and in vivo: implications in the treatment of restenosis after angioplasty.

Singh JP, Rothfuss KJ, Wiernicki TR, Lacefield WB, Kurtz WL, Brown RF, Brune KA, Bailey D, Dubé GP.

J Am Coll Cardiol. 1994 Mar 1;23(3):665-71.

20.

In vitro characterization of a novel TXA2/PGH2 receptor ligand (S-145) in platelets and vascular and airway smooth muscle.

Dubé GP, Mais DE, Jakubowski JA, Brune KA, Utterback BG, True TA, Rinkema LE, Kurtz WL.

J Pharmacol Exp Ther. 1992 Aug;262(2):784-91.

PMID:
1386888
21.

Characterization of a thromboxane A2/prostaglandin H2 receptor in guinea pig lung membranes using a radioiodinated thromboxane mimetic.

Saussy DL Jr, Mais DE, Dubé GP, Magee DE, Brune KA, Kurtz WL, Williams CM.

Mol Pharmacol. 1991 Jan;39(1):72-8.

PMID:
1824791

Supplemental Content

Loading ...
Support Center